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ABSTRACT: Detecting and segmenting brain metastases is a tedious and time-consuming task for many 
radiologists, particularly with the growing use of multi-sequence 3D imaging. This study demonstrate 
automated detection and segmentation of brain metastases on multi-sequence MRI using a deep 
learning approach based on a fully convolution neural network (CNN). In this retrospective study, a total 
of 156 patients with brain metastases from several primary cancers were included. Pre-therapy MR 
images (1.5T and 3T) included pre- and post-gadolinium T1-weighted 3D fast spin echo (CUBE), post-
gadolinium T1-weighted 3D axial IR-prepped FSPGR (BRAVO), and 3D CUBE fluid attenuated inversion 
recovery (FLAIR). The ground truth was established by manual delineation by two experienced 
neuroradiologists. CNN training/development was performed using 100 and 5 patients, respectively, 
with a 2.5D network based on a GoogLeNet architecture. The results were evaluated in 51 patients, 
equally separated into those with few (1-3), multiple (4-10), and many (>10) lesions. Network 
performance was evaluated using precision, recall, Dice/F1 score, and ROC-curve statistics. For an 
optimal probability threshold, detection and segmentation performance was assessed on a per 
metastasis basis. Wilcoxon rank sum test was used to test the differences between patient subgroups. 
The area under the ROC-curve (AUC), averaged across all patients, was 0.98±0.04. The AUC in the 
subgroups was 0.99±0.01, 0.97±0.05, and 0.97±0.03 for patients having 1-3, 4-10, and >10 metastases, 
respectively. Using an average optimal probability threshold determined by the development set, 
precision, recall, and Dice-score were 0.79±0.20, 0.53±0.22, and 0.79±0.12, respectively. At the same 
probability threshold, the network showed an average false positive rate of 8.3/patient (no lesion-size 
limit) and 3.4/patient (10 mm
3
 lesion size limit). In conclusion, a deep learning approach using multi-
sequence MRI can aid in the detection and segmentation of brain metastases.  
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INTRODUCTION 
Attributed in large by advances in effective and systemic 
treatment regimens of primary tumors, there has been an 
increase in the number of patients with metastatic cancer 
over the last decade (1). Brain metastases are one of the 
most common neurologic complications of cancer, most 
frequently originating from lung cancer, breast cancer, 
and malignant melanoma (2). In a survey including more 
than 26,000 patients, 12.1% of all patients with 
metastatic disease had brain metastases at diagnosis (3). 
Most patients present with three or fewer metastases to 
the brain, but 40% of patients have greater than this 
number (4, 5). Contrast-enhanced magnetic resonance 
imaging (MRI) is the key imaging technique in the 
diagnosis of brain metastases and is also used for 
longitudinal follow-up to assess treatment response. 
The detection and segmentation of brain 
metastases is essential in the management of patients 
with brain metastases. Manual detection and 
segmentation of brain metastases is tedious and time-
consuming, particularly with the growing use of multi-
sequence 3D imaging, but it is an important task for many 
radiologists that must be performed with high accuracy. 
This is most clearly demonstrated in segmenting brain 
metastases for planning stereotactic radiosurgery (SRS), 
given that overinclusion will result in healthy tissue being 
irradiated and under-inclusion will lead to inadequate 
treatment. Furthermore, the diagnostic methods for 
assessing treatment response follow the criteria 
formulated by the Response Assessment in Neuro-
Oncology (RANO) working group and are based on 
measuring the size of the enhancing lesion on Gadolinium 
(Gd) enhanced T1-weighted MR images (6). The 
traditional metrics used for response evaluation are 
based on unidimensional measurements, although the 
value of using volumetric measurements has been 
increasingly discussed. One concern raised by the RANO-
group was that volumetric analysis, as performed 
manually by radiologists, adds cost and complexity and is 
not available at all centers. 
During recent years, advances in machine 
learning (ML) have suggested the possibility of new 
paradigms in healthcare. One application of ML in 
radiology is the detection and segmentation of organs 
and pathology (7–10). In particular, there has been a 
significant effort in developing deep learning (DL) 
algorithms to learn from the comprehensive voxel-wise 
labeled MRI data for segmenting primary brain tumors 
(11–15). However, only a few studies have applied such 
ML approaches on patients with brain metastases (16–
18), which may require different approaches given their 
size and multiplicity. To this end, this work demonstrates 
the use of a fully convolution neural network (CNN) for 
automatic detection and segmentation of brain 
metastases using multi-sequence MRI data as input. 
 
MATERIALS AND METHODS 
Patient Population and Imaging Parameters 
This retrospective, single center study was approved by 
our Institutional Review Board.  Inclusion criteria included 
the presence of known or possible metastatic disease 
(i.e., presence of a primary tumor), no prior surgical or 
radiation therapy, and the availability of all required MR 
imaging sequences (see below). Only patients with ≥ 1 
metastatic lesion were included.  Mild patient motion was 
not an exclusion criterion. To be most inclusive, we 
included cases performed at both 1.5T and 3T from all our 
clinical scanners, which included all major vendors. Based 
on these criteria, a consecutive set of patients were 
identified, imaged between June 2016 and June 2018. 
Details on this cohort are shown in Table 1, along with a 
list of the primary cancers. 
The imaging protocol included pre- and post-
gadolinium T1-weighted 3D fast spin echo (CUBE), post-
gadolinium T1-weighted 3D axial IR-prepped FSPGR 
(BRAVO), and 3D CUBE fluid-attenuated inversion 
recovery (FLAIR). All sequences with key imaging 
parameters are summarized in Table 2. 
 
Image Segmentation and Co-registration 
Ground truth segmentations were established by two 
experienced neuroradiologists by manually delineating 
and cross-checking regions of interest (ROI) around each 
enhancing metastatic lesion. The lesions were outlined on 
each slice on the post-gadolinium 3D T1-weighted IR-
FSPGR sequence, with additional guidance from the 3D 
FLAIR and the post-gadolinium 3D T1-weighted spin echo 
data using the OsiriX MD software package (Version 8.0, 
Geneva, Switzerland). 
Pre/post-contrast T1 CUBE and FLAIR images 
were co-registered to the IR-FSPGR space by normalized 
mutual information co-registration using the nordicICE 
software package (NordicNeuroLab, Bergen, Norway). 
Prior to network training, the brain was extracted by 
  
Table 1: Demographics   
Total number of patients 156 
Gender 105 Female / 51 Male 
Primary cancer:  
 Lung 99 (63%) 
Breast 33 (21%) 
Skin/melanoma 7 (5%) 
Genitourinary 7 (5%) 
Gastrointestinal 5 (3%) 
Miscellaneous 5 (3%) 
Number of Metastases: Number of patients 
                            ≤3 64 (41%) 
                              4-10 47 (30%) 
                            >10 45 (29%)  
 
Figure 1: Flowchart showing the four image inputs used to train the neural network, the modified GoogLeNet 
architecture, and the resulting output colormap (overlaid a post-contrast BRAVO image) representing a probability map 
of whether the voxel represents a metastasis, ranging from 0-1. 
Table 2: Overview of MRI pulse sequences and key imaging parameters 
Technique 3D T1 BRAVO Pre/Post 3D T1 CUBE 3D CUBE FLAIR 
TR (ms)
 *
 12.02 / 8.24 550 / 602 6000 
TE (ms)
* 
5.05 / 3.24 9.54 / 12.72 119 / 136 
Flip angle
*
 20 / 13 90 90 
FOV (mm
2
) 240×240 250×250 240×240 
Inversion time (ms)
 *
 300 / 400 - 1880 / 1700 
Acquisition matrix 256×256 256×256 256×256 
Slice thickness (mm) 1 1 1 – 1.6 
# of slices 160 270 – 320 270 – 320 
Slice acquisition plane Axial Sagittal Sagittal 
TR = repetition time, TE = echo time, FOV = field-of-view, BRAVO – T1-weighted inversion recovery prepped fast spoiled 
gradient-echo, CUBE – T1-weigthed fast spin-echo, FLAIR – fluid attenuated inversion recovery. 
*
 In case of varying parametric values between field strength, ’/’ notation is given (1.5T / 3T) 
 
using the Brain Extraction Tool (BET) (19) and applying the 
resulting brain masks on the network’s input data. The 
brain masks were generated from the pre-contrast T1-
weighted 3D CUBE imaging series and propagated to the 
other sequences. 
 
Convolutional Neural Network Details 
Training was performed using a 2.5D fully CNN based on 
the GoogLeNet architecture (20) (Figure 1). The network 
was modified to optimize segmentation by skipping the 
first and third down-sampling max pooling layers and 
using a stride of one on the first 7x7 convolutional layer. 
As a result, the final down-sampling rate throughout the 
convolutional layers were 4×, rather than 32×. To make 
the network fully convolutional, GoogLeNet’s final fully  
connected layers were replaced by a single convolutional 
transpose layer of stride 4 and size 8x8. The final 
prediction was made on a single channel of logit values 
with a sigmoid cross-entropy loss function. In order to 
counter learning hurdles introduced by an unbalanced 
dataset, the loss on positive ground truth voxels were 
weighted 10× more than the loss on negative ground 
truth voxels.  
To better capture through-plane features 
without incurring the inefficiencies associated with true 
3D CNN’s, we implemented a ‘2.5D’ model.  The 
network’s input were 7 slices from each of the four 
aforementioned sequences, comprising a single center 
slice with 3 slices above and below, resulting in an input 
channel dimension of 28. Each image was rescaled (if 
necessary) to a size of 256×256. Note that all MR images 
were originally 256×256 or 512×512, and that bilinear 
interpolating the 512×512 images down to 256×256 gave 
minimal artifacts. Prior to training, pre-processing and 
normalization was performed with independent 
histogram equalization on each slice of the 28-channel 
input. During training, we randomly flipped and rotated 
the images in multiples of 90 degrees for data 
augmentation. 
All training was performed on two consumer-
grade graphical processing units (GPU’s) (NVIDIA GeForce 
GTX 1080TI). The batch size was 32 with a learning rate of 
0.001. Given that there were far more frames (>30×) 
without lesions compared to frames with lesions, we 
employed an uneven sampling procedure. For 16 of 32 
images in each batch, we sampled the image from the set 
of frames with at least some lesion. For the other 16 
images, we sampled uniform randomly from all 
frames. This ensured that for each batch, at least half of 
the images was populated with frames including some 
ground truth lesions. Regularization was performed by a 
L2 weight decay with a decay constant of 1e
-5
. Batch 
normalization was used following every convolutional 
layer. We used the ADAM optimization method (21) with 
default TensorFlow beta values of 0.9 and 0.999. By 
defining an epoch as the statistical equivalent of seeing 
every distinct frame of the dataset once, the training 
continues until convergence, which occurred at about the 
10
th
 epoch. The network was trained using TensorFlow, 
and the resulting output was an image for each slide 
representing a probability map of whether the voxel 
represents a metastasis, ranging from 0-1. 
The total number of cases were randomly broken 
into separate train, development, and test sets. None of 
the cases in the test set were present in the training set. 
To ensure a representative sample in our test set, we first 
chose the test cases as follows. First, we determined the 
number of distinct metastatic lesions in each case in the 
entire cohort and then broke the data into groups with (a) 
1-3, (b) 4-10, (c) >10 lesions. We then randomly selected 
17 cases from each of these groups, leading to a total test 
set size of 51 cases. The remaining cases were divided 
into training and development sets in a random 20:1 
ratio. 
 
Statistical Analysis 
The network’s ability to detect metastases on a voxel-by-
voxel basis was evaluated using receiver operating 
characteristic (ROC) curve statistics, measuring the area 
under the ROC curve (AUC) for each patient in the test 
set. Only voxels within the brain mask were considered 
when calculating AUC. Corresponding sensitivity and 
specificity were determined by using the maximum value 
of the Youden’s index as a criterion for selecting the 
optimal cut-off point. Based on ROC statistics from the 
development set, the optimal probability threshold for 
including a voxel as a metastasis was determined, and 
using this threshold, the results were further evaluated in 
terms of detection accuracy using precision and recall, 
and segmentation accuracy using the Dice similarity score 
(also known as the F1 score). In addition to the voxel-by-
voxel analysis, the detection performance was also 
evaluated on a lesion-by-lesion basis by calculating the 
number of false positive (FP) per case. These metrics were 
determined by comparing the ground truth maps and the 
prediction maps, counting the number of overlapping 
objects using a connecting component approach. The 
number of FP were determined both without and with a 
lesion-size criterion, in which only objects ≥ 10 mm
3
 were 
considered a detected lesion. Finally, the Wilcoxon rank 
sum test was used to compare the detection and 
segmentation metrics between the patient subgroups. A 
statistical significance level of 5% was used. All statistical 
analyses were performed using MATLAB R2017a version 
9.2.0 (MathWorks Inc. Natick, MA).  
 
RESULTS 
A total of 156 patients were included in the study, with a 
final breakdown of 100 training cases, 5 development 
cases, and 51 test cases. The total time for training the 
neural network was approximately 15 hrs. For processing 
a test case, the forward pass on a single NVIDIA GTX 
1080Ti GPU took less than 200 ms per slice during test 
time with a run time of approximately 1 minute for a full 
MR volume. Mean patient age was 63±12 years (range: 
29-92 years). Primary malignancies included lung (n=99), 
breast (n=33), melanoma (n=7), genitourinary (n=7), 
gastrointestinal (n=5), and miscellaneous cancers (n=5). 
Of the 156 patients included, 64 (41%) had 1-3 
metastases, 47 (30%) had 4-10 metastases, and 45 (29%) 
had >10 metastases. The test set of 51 patients had a 
total of 856 lesions. 
Figure 2 shows an example case demonstrating 
the resulting probability map as an overlay on the post-
gadolinium FSPGR image series using a lower probability 
threshold of 0.1. The voxel-by-voxel detection 
performance showed an area under the ROC-curve, 
averaged across all patients, of 0.98±0.04, corresponding 
to a sensitivity and specificity of 94% and 97%, 
respectively, at the optimal cut-off point. Further, the 
subgroups showed an area under the ROC-curve of 
0.99±0.01 for patients having 1-3 metastases, 0.97±0.05 
for 4-10 metastases, and 0.97±0.03 for >10 metastases, 
respectively (Fig. 3). The corresponding sensitivity and 
specificity are shown in Table 3A. The average optimal 
probability threshold for including a voxel as a metastasis, 
measured in the development set, was 0.93. Using this 
threshold, the precision, recall, and Dice-score were 
Figure 2: Example case of a 47-year-old female patient presenting with three brain metastases from lung cancer. The 
image mosaic shows the predictions (probability maps as indicated by the color bar), generated by the neural network, 
and manually delineated metastases (yellow lines) overlaid the post-contrast image. 
Figure 3: ROC curves with 95% confidence intervals 
(shaded areas) for the three subgroups having 1-3 
metastases (green), 4-10 metastases (red), and >10 
metastases (blue). The average area under the ROC 
curve was 0.98, ranging from 0.79 to 1.00 for all cases. 
0.79±0.20, 0.53±0.22, and 0.79±0.12, respectively. The 
distribution of these metrics within the subgroups is 
shown Table 3B. On a lesion-by-lesion basis, and by using 
the optimal probability threshold (average sensitivity = 
83%), the network showed an average FP-rate of 8.3 (no 
size limit) and 3.4 (10 mm
3
 size limit) lesions per case, 
with the highest sensitivity and lowest numbers of FP in 
patients with few metastases (Table 3C). The P-values, 
testing the differences in all detection and segmentation 
metrics between the subgroups, are shown in Table 4A-C. 
Examples in representative cases with different numbers 
of metastases are shown in Figure 4.  
 
DISCUSSION 
This study demonstrates that a modified 2.5D GoogLeNet 
CNN can detect and segment brain metastases on multi-
sequence MRI with high accuracy. By testing on a large 
number of patients, thus facilitating subgroup analysis, 
this work demonstrates the network’s clinical 
performance and potential, in addition to better 
understanding of its generalizability. To our knowledge, 
no previous study has reported on subgroup analysis 
using deep learning in brain metastases segmentation. 
In recent years, many deep learning approaches 
have been developed and tested for automatic 
segmentation of gliomas (22), thanks in part to the 
publicly available BRAin Tumor Segmentation (BraTS) 
dataset. In contrast, only a few studies have used this 
approach for brain metastases. Liu et al. investigated the 
use of a CNN-based segmentation for SRS planning and 
reported a Dice-score of 0.67 and an AUC of 0.98 (16). 
The performance of the current method is superior to this 
prior method based on the average Dice-score (0.79 vs. 
0.67), but showed similar AUC performance. Charron et 
al. used a 3D CNN (DeepMedic) for automatic detection  
  
Table 3: Summary of detection and segmentation metrics (mean value ± standard deviation) 
A: Voxel-by-voxel detection accuracy using ROC statistics
*
 
# of metastases AUC Sensitivity Specificity 
1 to 3 0.99±0.01 98±3% 98±2% 
4 to 10 0.97±0.05 92±10% 97±3% 
>10 0.97±0.03 92±7% 95±3% 
All cases 0.98±0.04 94±8% 97±3% 
    B: Detection and segmentation accuracy at an optimal probability threshold
**
 
# of metastases Dice Recall Precision 
1 to 3 0.76±0.20 0.54±.026 0.79±0.27 
4 to 10 0.83±0.04 0.59±0.21 0.76±0.22 
>10 0.78±0.05 0.44±0.18 0.81±0.11 
All cases 0.79±0.12 0.53±0.22 0.79±0.20 
    C: Lesion-by-lesion detection accuracy at an optimal probability threshold
**
 
# of metastases Sensitivity FP (no size limit) FP (10mm
3
 size limit) 
1 to 3 92±25% 3.2±4.0 1.7±2.0 
4 to 10 81±19% 8.5±9.8 4.4±6.0 
>10 76±20% 13.1±18.9 4.1±10.3 
All cases 83±22% 8.3±12.9 3.4±7.0 
AUC = area under the receiver operating characteristic (ROC) curve, FP = false positive. 
*
Sensitivity and specificity were determined by using the maximum value of the Youden’s index 
**
The metrics were estimated using an optimal probability threshold of 0.93, as determined from the 
development set.  
 
 
Table 4: P-values comparing subgroups using Wilcoxon rank sum test 
A: Voxel-by-voxel detection accuracy using ROC statistics
*
 
Subgroups AUC Sensitivity Specificity 
G1 vs G2 0.0131 0.0017 0.0496 
G1 vs G3 0.0024 0.0024 0.0038 
G2 vs G3 0.4282 0.6794 0.0421 
    B: Detection and segmentation accuracy at an optimal probability threshold
**
 
Subgroups Dice Recall Precision 
G1 vs G2 1.0000 0.5816 0.2557 
G1 vs G3 0.0629 0.1131 0.2557 
G2 vs G3 0.0915 0.0230 0.8633 
    C: Lesion-by-lesion detection accuracy at an optimal probability threshold
**
 
Subgroups Sensitivity FP (no size limit) FP (10mm
3
 size limit) 
G1 vs G2 0.0069 0.0158 0.0829 
G1 vs G3 0.0002 0.0139 0.6352 
G2 vs G3 0.3952 0.7031 0.1178 
G1 = subgroup having 1-3 metastases, G2 = subgroup having 4-10 metastases, G3 = subgroup having 
>10 metastases. Significant p-values are highlighted in bold. All P-values were measured using the 
Wilcoxon rank sum test. 
*
Sensitivity and specificity were determined by using the maximum value of the Youden’s index. 
**
The metrics were estimated using an optimal probability threshold of 0.93, as determined from the 
development set.  
  
Figure 4: Examples in representative cases with few (top 
row), moderate (middle row), and extensive (bottom row) 
metastatic disease. The top row shows a 70-year-old 
woman presenting with one brain metastasis from colon 
carcinoma. The middle row shows a 68-year-old man 
presenting with seven brain metastases from lung cancer. 
The bottom row shows a 37-year-old man presenting with 
seventy-eight brain metastases from lung cancer. The 
network’s predictions are shown as probability maps and 
the yellow lines show the manually delineated lesions. 
 
 
and segmentation of brain metastases (17). By using 
segmented metastases to be irradiated as the ground 
truth, their network was trained using three MRI 
sequences from 146 patients as input and further tested 
on 18 patients. Similar to our study, their network was 
trained using three MRI sequences which proved to 
outperform networks trained on a single MRI contrast. 
Their network showed a sensitivity of 98% and 7.2 false 
positive per patient. Sunwoo et al. developed a 
computer-aided diagnostic (CAD) system for detecting 
brain metastases and a neural network for false-positive 
reduction (23). Their CAD system significantly improved 
the diagnostic performance of the reviewers and showed 
an overall sensitivity of 87%. One feature that separates 
our work from these previous studies is the strength of 
having diverse data, which may make it more challenging 
to demonstrate an overall high performance. We included 
cases from both 1.5T and 3T using multi-vendor scanners, 
and our data was not limited to patients receiving SRS, 
thus including more patients with extensive metastases 
disease (>10). This is supported by our results which 
indicate that the neural networks ability to detect and 
segment of brain metastases were reduced in patients 
with higher number of metastases. However, our patient 
cohort is more representative of real-world data. 
Furthermore, there are also differences in network 
architecture. Whereas Charron et al. used a full 3D 
network, we used a 2.5D network. The results indicate 
that our 2.5D network achieves the same segmentation 
performance as a 3D network, which reduces the 
computational and memory requirements for training. 
However, further studies systematically comparing 2D, 
2.5D, and 3D neural architectures must be performed to 
adequately answer this question. Also note that, using 
comparable graphic cards, our 2.5D network required 
approximately 1 minute to perform a forward pass 
(inference) while a 3D network would require 
approximately 20 minutes for the same task. 
The split between training/validation/testing in 
this study is somewhat unusual compared to similar 
studies in the literature. However, we chose to test on a 
large number of cases to understand how generalizable 
the network was and to facilitate subgroup analysis, 
enabling a better understanding of the network’s clinical 
performance and potential. In earlier stages of the study, 
we found that the network had high performance training 
on approximately half of the current training set, and that 
increasing the number of training cases did not provide 
significant improvement, thus justifying our use of a 
larger test set. Our results indicate that the networks 
ability to detect metastatic voxels, as measured by the 
AUC, is best in patients with few (1-3) metastases and 
further that the segmentation performance, as measured 
by the Dice-score, is slightly better for patients with 4-10 
metastases. On a lesion-by-lesion basis, our results 
suggest that the network performs best on patients with 
few metastases, both in terms of sensitivity and the 
number of false positive. One hypothesis is that these 
results may be associated with an optimal tradeoff 
between total number and individual size of the 
metastases.  
Multiple network architectures were considered 
for this project, including residual networks (24), dense 
networks (25), U-Nets (26), Pyramid Scene Parsing (PSP) 
Nets (27), and Feature Pyramid Networks (FPNs) (28). 
However, after running preliminary experiments with the 
2014 GoogLe (or Inception v1) network, we found that 
this was already capable of overfitting the training data. 
Thus, given that network complexity and capacity were 
not driving issues in the project, and that the GoogLeNet 
enables high computational efficiency, both in memory 
and speed, this became our choice of architecture. The 
compact size of the network allows it to be run on even 
the smallest mobile GPUs, such as the NVIDIA Tegra chip. 
However, note that more ample gains from advanced 
network architectures could be attained with larger 
datasets. 
Typical workflow in radiotherapy planning 
requires accurate detection by a radiologist, followed by 
segmentation by a radiation therapist. Both steps are 
time-consuming and subject to interobserver variation. 
Detection requires manual visualization and annotation. 
Fatigue and image quality are a few factors that may 
affect the accuracy (29, 30). Special imaging techniques 
have been proposed to improve this process. For 
instance, double dose gadolinium-based contrast-
enhanced thin-slice MRI produced more precise 
delineation of lesions compared to using single dose (31). 
The addition of overlapping CUBE maximum intensity 
projection (MIP) images, which have better contrast-to-
noise ratio of metastatic lesions than post-gadolinium 3D 
isometric high-resolution sequences, are often used to 
enhance the sensitivity of detection. However, even with 
the addition of CUBE MIP images, the interrater 
agreement for identification of metastases between 2 
experienced radiologists was reported as only fair-to-
moderate in one study (32). Segmentation requires 
tracing the contours of the lesions on the 2D images slice 
by slice. Even though there is semi-automatic software 
available for segmentation, extensive manual editing is 
often required, thus generating non-reproducible 
operator-dependent results (33, 34). Accurate 
segmentation of the metastases is imperative in radiation 
therapy planning to minimize damage to adjacent normal 
tissue. Our neural network essentially combines 
visualization, quantification, and segmentation into one 
fluent step, producing results that can be directly applied 
to radiotherapy planning, with minimal user-interaction. 
While this study shows high accuracy and 
performance using deep learning for segmenting brain 
metastasis, several potential study limitations exist. First, 
the results must be interpreted in light of the limited 
sample size in this single center, retrospective study. This 
is partly related to the time required for manual 
segmentation. Future studies will investigate the use of 
‘coarse’ segmentation, which is by far less time-
consuming compared to fine segmentation, and how this 
may affect the network’s ability to detect and segment 
brain metastases. Also, testing of the network 
performance on multi-site data remains a key step 
towards understanding its clinical value. Second, the 
network sometimes fails in terms of reporting FP. This is 
particularly true in and near vascular structures at the 
skull base such as venous sinuses, or over the 
cortex. Finally, as our neural network is trained on four 
distinct MRI contrasts, the use of this method is limited to 
sites acquiring all sequences. However, future studies will 
address the issue of having other or even lacking model 
inputs with the aim of making the neural network more 
robust and versatile towards different input channels. 
In conclusion, our study demonstrates that a 
deep learning network can detect and segment brain 
metastases on multi-sequence MRI with high accuracy 
and thus illustrates the potential use of this technique in a 
clinically relevant setting. 
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